Literature DB >> 22205033

Anergic CD8+ T lymphocytes have impaired NF-κB activation with defects in p65 phosphorylation and acetylation.

Paúl E Clavijo1, Kenneth A Frauwirth.   

Abstract

Because of the cytotoxic potential of CD8(+) T cells, maintenance of CD8(+) peripheral tolerance is extremely important. A major peripheral tolerance mechanism is the induction of anergy, a refractory state in which proliferation and IL-2 production are inhibited. We used a TCR transgenic mouse model to investigate the signaling defects in CD8(+) T cells rendered anergic in vivo. In addition to a previously reported alteration in calcium/NFAT signaling, we also found a defect in NF-κB-mediated gene transcription. This was not due to blockade of early NF-κB activation events, including IκB degradation and NF-κB nuclear translocation, as these occurred normally in tolerant T cells. However, we discovered that anergic cells failed to phosphorylate the NF-κB p65 subunit at Ser(311) and also failed to acetylate p65 at Lys(310). Both of these modifications have been implicated as critical for NF-κB transactivation capacity, and thus, our results suggest that defects in key phosphorylation and acetylation events are important for the inhibition of NF-κB activity (and subsequent T cell function) in anergic CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205033      PMCID: PMC3262885          DOI: 10.4049/jimmunol.1100793

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

Review 1.  Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha.

Authors:  R T Hay; L Vuillard; J M Desterro; M S Rodriguez
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

2.  Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway.

Authors:  M Leitges; L Sanz; P Martin; A Duran; U Braun; J F García; F Camacho; M T Diaz-Meco; P D Rennert; J Moscat
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

3.  CTLA-4 is not required for induction of CD8(+) T cell anergy in vivo.

Authors:  K A Frauwirth; M L Alegre; C B Thompson
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

4.  PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes.

Authors:  Z Sun; C W Arendt; W Ellmeier; E M Schaeffer; M J Sunshine; L Gandhi; J Annes; D Petrzilka; A Kupfer; P L Schwartzberg; D R Littman
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

Review 5.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

6.  Regulation of activator protein-1 and NF-kappa B in CD8+ T cells exposed to peripheral self-antigens.

Authors:  S Guerder; M Rincòn; A M Schmitt-Verhulst
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

7.  NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development.

Authors:  R E Voll; E Jimi; R J Phillips; D F Barber; M Rincon; A C Hayday; R A Flavell; S Ghosh
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

8.  Duration of nuclear NF-kappaB action regulated by reversible acetylation.

Authors:  W Fischle; E Verdin; W C Greene
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

9.  NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta.

Authors:  N Coudronniere; M Villalba; N Englund; A Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling.

Authors:  Dan Levy; Alex J Kuo; Yanqi Chang; Uwe Schaefer; Christopher Kitson; Peggie Cheung; Alexsandra Espejo; Barry M Zee; Chih Long Liu; Stephanie Tangsombatvisit; Ruth I Tennen; Andrew Y Kuo; Song Tanjing; Regina Cheung; Katrin F Chua; Paul J Utz; Xiaobing Shi; Rab K Prinjha; Kevin Lee; Benjamin A Garcia; Mark T Bedford; Alexander Tarakhovsky; Xiaodong Cheng; Or Gozani
Journal:  Nat Immunol       Date:  2010-12-05       Impact factor: 25.606

View more
  22 in total

1.  Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.

Authors:  Lillian Seu; Steffanie Sabbaj; Alexandra Duverger; Frederic Wagner; Joshua C Anderson; Elizabeth Davies; Frank Wolschendorf; Christopher D Willey; Michael S Saag; Paul Goepfert; Olaf Kutsch
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

Review 2.  Regulation of nuclear factor-κB in autoimmunity.

Authors:  Shao-Cong Sun; Jae-Hoon Chang; Jin Jin
Journal:  Trends Immunol       Date:  2013-02-20       Impact factor: 16.687

3.  Simultaneous assessment of NF-κB/p65 phosphorylation and nuclear localization using imaging flow cytometry.

Authors:  Orla Maguire; Kieran O'Loughlin; Hans Minderman
Journal:  J Immunol Methods       Date:  2015-04-07       Impact factor: 2.303

4.  A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.

Authors:  Tobias Goldmann; Peter Wieghofer; Philippe F Müller; Yochai Wolf; Diana Varol; Simon Yona; Stefanie M Brendecke; Katrin Kierdorf; Ori Staszewski; Moumita Datta; Tom Luedde; Mathias Heikenwalder; Steffen Jung; Marco Prinz
Journal:  Nat Neurosci       Date:  2013-09-29       Impact factor: 24.884

Review 5.  TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex.

Authors:  Jian-hong Shi; Shao-Cong Sun
Journal:  Mol Immunol       Date:  2015-08-08       Impact factor: 4.407

6.  Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer.

Authors:  James W Opzoomer; Jonathan Caron; Tamara Muliaditan; Mary Okesola; Paris Kosti; Sharanpreet Lall; Mieke Van Hemelrijck; Francesco Dazzi; Andrew Tutt; Anita Grigoriadis; Cheryl E Gillett; Stephen F Madden; Joy M Burchell; Shahram Kordasti; Sandra S Diebold; James F Spicer; James N Arnold
Journal:  Clin Cancer Res       Date:  2018-01-16       Impact factor: 12.531

7.  T Cell Receptor-induced Nuclear Factor κB (NF-κB) Signaling and Transcriptional Activation Are Regulated by STIM1- and Orai1-mediated Calcium Entry.

Authors:  Xiaohong Liu; Corbett T Berry; Gordon Ruthel; Jonathan J Madara; Katelyn MacGillivray; Carolyn M Gray; Lisa A Madge; Kelly A McCorkell; Daniel P Beiting; Uri Hershberg; Michael J May; Bruce D Freedman
Journal:  J Biol Chem       Date:  2016-01-29       Impact factor: 5.157

Review 8.  Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity.

Authors:  Katherine A Waugh; Sonia M Leach; Jill E Slansky
Journal:  Vaccines (Basel)       Date:  2015-09-17

9.  Tumor Extracellular Matrix Stiffness Promptly Modulates the Phenotype and Gene Expression of Infiltrating T Lymphocytes.

Authors:  Maila Chirivì; Fabio Maiullari; Marika Milan; Dario Presutti; Chiara Cordiglieri; Mariacristina Crosti; Maria Lucia Sarnicola; Andrea Soluri; Marina Volpi; Wojciech Święszkowski; Daniele Prati; Marta Rizzi; Marco Costantini; Dror Seliktar; Chiara Parisi; Claudia Bearzi; Roberto Rizzi
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

10.  Importance of suitable reference gene selection for quantitative RT-PCR during ATDC5 cells chondrocyte differentiation.

Authors:  Zhichen Zhai; Yongchang Yao; Yingjun Wang
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.